Cencora

ABC · NYSE

$343.27+$3.27 (+0.96%)TodayMarket closed ·
Prev close $340.00

Revenue by product and region

Fiscal year ended Sep 30, 2015: $135.96B total revenue

By product

  • Pharmaceutical Distribution [Member]$131.48B96.7%
  • All Other Segments [Member]$4.77B3.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Cencora suppliers and customers
CompanyRelationshipCorrelation
Amphastar Pharmaceuticals AMPHSupplier0.96
WPT Industrial Real Estate Investment TrustSupplier0.96
AbbVie Inc. ABBVSupplier0.95
Kindred Biosciences, Inc. KINSupplier0.88
Suzuken Co., Ltd.Customer0.84
Pacira Biosciences PCRXSupplier0.84
Alexion Pharmaceuticals, Inc. ALXNSupplier0.84
Assertio Holdings ASRTSupplier0.83
Cigna Corporation CICustomer0.77
Eli Lilly LLYSupplier0.77

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.